Literature DB >> 9848101

Spatial and temporal expression of angiogenic molecules during tumor growth and progression.

R Kumar1, H Kuniyasu, C D Bucana, M R Wilson, I J Fidler.   

Abstract

The growth and metastasis of cancer directly correlates with tumor angiogenesis. A better understanding of the expression of regulatory factors controlling angiogenesis is important in exploiting this process therapeutically. Our present study demonstrates that small tumors (3-4 mm in diameter) express more basic fibroblast growth factor (bFGF) and interleukin 8 (IL-8) than large tumors (> 10 mm in diameter), whereas more vascular endothelial growth factor (VEGF) is expressed in large tumors. Immunostaining showed a heterogeneous distribution of angiogenic factors within the tumor; expression of bFGF and IL-8 was highest on the periphery of a large tumor, where cell division is maximum. VEGF expression was higher in the center of the tumor. In vitro studies demonstrated that sparse cultures of tumor cells expressed higher levels of bFGF and IL-8 than confluent cultures. In contrast, the expression of bFGF and IL-8 was not diminished in tumor cells growing on confluent monolayers of normal cells. VEGF expression was upregulated by cell density irrespective of contact with tumor cells or normal cells. These results demonstrate that the expression of different angiogenic factors in tumor cells can be regulated by their proximity to other tumor cells or host cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848101

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  17 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 2.  Origins of regulated cell-to-cell variability.

Authors:  Berend Snijder; Lucas Pelkmans
Journal:  Nat Rev Mol Cell Biol       Date:  2011-01-12       Impact factor: 94.444

3.  Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis.

Authors:  Scott S Verbridge; Nak Won Choi; Ying Zheng; Daniel J Brooks; Abraham D Stroock; Claudia Fischbach
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

4.  Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha.

Authors:  S Ozawa; H Shinohara; H O Kanayama ; C J Bruns; C D Bucana; L M Ellis; D W Davis; I J Fidler
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

5.  Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer.

Authors:  H Kuniyasu; W Yasui; H Shinohara; S Yano; L M Ellis; M R Wilson; C D Bucana; T Rikita; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

6.  Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.

Authors:  Huaijun Wang; Osamu F Kaneko; Lu Tian; Dimitre Hristov; Jürgen K Willmann
Journal:  Invest Radiol       Date:  2015-05       Impact factor: 6.016

7.  Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.

Authors:  Kejia Cai; He N Xu; Anup Singh; Lily Moon; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

8.  VEGFR2-Targeted Three-Dimensional Ultrasound Imaging Can Predict Responses to Antiangiogenic Therapy in Preclinical Models of Colon Cancer.

Authors:  Jianhua Zhou; Huaijun Wang; Huiping Zhang; Amelie M Lutz; Lu Tian; Dimitre Hristov; Jürgen K Willmann
Journal:  Cancer Res       Date:  2016-05-20       Impact factor: 12.701

9.  In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.

Authors:  Sung K Chang; Imran Rizvi; Nicolas Solban; Tayyaba Hasan
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

10.  Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.

Authors:  Rebekah R White; Siqing Shan; Christopher P Rusconi; Geetha Shetty; Mark W Dewhirst; Christopher D Kontos; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.